Sign in

CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
611547851
Phone
(858) 500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 8-K Event Other events
  4. 4 Planned sale Chief Legal Officer sold 1,559 shares at $5.96 ($9,292)
  5. 4 Planned sale Chief Operating Officer sold 1,558 shares at $6.28 ($9,777)
  6. 144 Insider Sale of Securities
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. ARS Other Annual Report to Security Holders
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. DEFA14A Proxy Proxy Materials
  15. DEF 14A Proxy Proxy Statement
  16. 4 Open-market sale Director sold 22,682 shares at $8.00 ($181,456)
  17. 144 Insider Sale of Securities
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. 10-K Report Annual Report
  20. 8-K Event Results of operations

Page 8 of 41 · 809 filings